Limitations in the Use of Rifampicin-Gelatin Grafts Against Virulent Organisms

Journal of Vascular Surgery - United States
doi 10.1067/mva.2002.121850
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

In Vitro Evidence of Improved Antimicrobial Efficacy of Silver and Triclosan Containing Vascular Grafts Compared With Rifampicin Soaked Grafts

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Use of Autogenous Bone Grafts

Clinical Oral Implants Research
Oral Surgery
2017English

The Synergistic Effect of Exogenous Glutamine and Rifampicin Against Mycobacterium Persisters

Frontiers in Microbiology
Microbiology
2018English

The Use and Abuse of Bone Grafts

BMJ
1917English

The Scope and Limitations of the Presumption Against Extraterritoriality

AJIL Unbound
Law
2016English

Use of the Low Virulent Strain Antigens in Serological Diagnosisof Tsutsugamushi Disease

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
1984English

Acute Tubulointerstitial Nephritis Due to the Use of Rifampicin. Case Report

Case reports
2020English

The Use of Autologous Fat Grafts in Breast Surgery: A Literature Review

Archives of Plastic Surgery
Surgery
2019English

In Vitro Activity of the Trinem Sanfetrinem (GV104326) Against Gram-Positive Organisms.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy